Visilant
Visilant is a commercial-stage social enterprise that uses AI-powered mobile technology to provide accessible, high-quality eye screening and care in low-resource settings. Their smartphone-based imaging system enables health workers with no prior ophthalmology training to capture clinical-grade eye images, which are then interpreted by AI models to diagnose and refer sight-threatening eye diseases. The platform also includes telemedicine technology to connect patients to eye doctors for further care, including surgery. Visilant partners with charitable eye hospitals, governments, and NGOs, impacting over 8 million patients annually, and has screened 30,000 patients while training 105 health workers. Their technology is clinically validated with high diagnostic concordance and is designed to radically expand access to eye care globally, especially in underserved communities.
Visilant
Visilant is a commercial-stage social enterprise that uses AI-powered mobile technology to provide accessible, high-quality eye screening and care in low-resource settings. Their smartphone-based imaging system enables health workers with no prior ophthalmology training to capture clinical-grade eye images, which are then interpreted by AI models to diagnose and refer sight-threatening eye diseases. The platform also includes telemedicine technology to connect patients to eye doctors for further care, including surgery. Visilant partners with charitable eye hospitals, governments, and NGOs, impacting over 8 million patients annually, and has screened 30,000 patients while training 105 health workers. Their technology is clinically validated with high diagnostic concordance and is designed to radically expand access to eye care globally, especially in underserved communities.
TL;DR
What they do: Commercial-stage social enterprise using AI and smartphone imaging to expand access to eye screening and telemedicine for treatable vision loss.
Flagship product: Seeker™ — smartphone-based anterior-segment imaging system plus AI interpretation and telemedicine workflow (Screen / Interpret / Connect).
Traction: Reportedly screened 30,000 patients and trained 105 health workers.
Origin: Spun out of Johns Hopkins University; founded by a multidisciplinary team.
Two disclosed grant rounds (May 10, 2022 and Mar 6, 2025); investors listed include Fast Forward and FastForward U.
Company Overview
Problem Domain
Preventable and treatable vision loss due to limited access to eye screening and specialist care in underserved settings.
Industry
Digital health; eye care
Tech Stack
Funding Track Record
Investor Signal
“Publicly listed funders include Fast Forward and FastForward U (grant funding).”